Allogeneic blood transfusion, hospital charges, and length of hospitalization: A study of 487 consecutive patients undergoing colorectal cancer resection

Archives of Pathology and Laboratory Medicine

Volumn 122, Issue 2, 1998, Pages 145-151

  Vamvakas, Eleftherios C ^a,b   Carven, Joan H ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; COLON RESECTION; COLORECTAL CANCER; COST BENEFIT ANALYSIS; FEMALE; HEALTH CARE COST; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; SEPSIS;

AGED; BLOOD TRANSFUSION; COLORECTAL NEOPLASMS; FEMALE; HOSPITAL CHARGES; HUMANS; LENGTH OF STAY; MALE; POSTOPERATIVE COMPLICATIONS;

EID: 0031930073     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Munoz E, Greenberg R, Dietzek A, Goldstein J, Bank S, Wise L. The identifier concept: clinical parameters to stratify hospital costs within gastroenterology DRGs. Am J Gastroenterol. 1987;82:1250-1255.
2. Munoz E, Friedman R, Schroder W, Gross H, Goldstein J, Wise L. Age, resource consumption, and outcome for surgical patients at an academic medical center. Surgery. 1988;103:335-343.
3. Munoz E, Shamash F, Kassan M, Wise L. The costs and dynamics of surgical morbidity and mortality. Surgery 1986;100:905-911.
4. Munoz E, Seltzer V, Dietzek A, Pace B, Goldstein J, Wise L. The identifier concept: clinical parameters to stratify hospital patient costs within gynecology diagnosis-related groups. Am J. Obstet Gynecol 1988;158:1176-1182.
5. Munoz E, Luber J, Ratner L, Goldstein J, Margolis I, Wise L. The identifier concept: variables to stratify patient costs within cardiothoracic surgical diagnostic-related groups. J Thorac Cardiovasc Surg. 1988;96:376-381.
6. Munoz E, Choen J, Zelnick R, Mulloy K, Margolis I, Wise L. Hospital costs by clinical parameters for peripheral vascular surgical DRGs. J Cardiovasc Surg. 1989;30:58-63.
7. Munoz E, Angus G, Calabro S, Mulloy K, Wise L. Drgs, costs, and outcome for plastic surgical patients. Plast Reconstr Surg. 1988;82:116-124.
8. Munoz E, Chalfin D, Calabro S, Goldstein JD, Wise L. Costs of pulmonary medicine and DRGs: access and quality of care for the future. Am Rev Respir Dis 1988;137:964-968.
9. Tartter PI. Determinants of postoperative stay in patients with colorectal cancer: implications for diagnostic-related groups. Dis Colon Rectum. 1988;31: 694-698.
10. Munoz E, Margolis I, Wise L. Surgonomics: the cost of gastrointestinal hemorrhage, the identifier concept. Am J Gastroenterol. 1985;80:139-142.
11. Jensen LS, Grunnet N, Hanberg-Sorensen F, Jorgensen J. Cost-effectiveness of blood transfusion and white cell reduction in elective colorectal surgery. Transfusion. 1995; 35:719-722.
12. Blumberg N, Kirkley SA, Heal JM. A cost analysis of autologous and allogeneic transfusions in hip replacement surgery. Am J Surg. 1996;171:324-330.
13. Jensen LS, Andersen AJ, Christiansen PM, et al. Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg. 1992;79:513-516.
14. Heiss MM, Mempel W, Jauch KW, et al. Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgery. Lancet. 1993;342:1328-1333.
15. Bordin JO, Heddle NM, Blajchman MA. Biologic effects of leukocytes present in transfused cellular blood products. Blood. 1994;84:1703-1721.
16. Klein HG. Immunomodulation caused by blood transfusion. In: Petz LD, Swisher SN, Kleinman S, Spence RK, Strauss RG, eds. Clinical Practice of Transfusion Medicine. New York, NY: Churchill Livingstone Inc; 1995:59-69.
17. Blumberg N, Heal JM. Immunomodulation by blood transfusion: an evolving scientific and clinical challenge. Am J Med. 1996;101:299-308.
18. Tartter PI. Blood transfusion and bacterial infections: clinical studies. In: Singal DP, ed. Immunological Effects of Blood Transfusion. Boca Raton, Fla: CRC Press; 1994:111-126.
19. Vamvakas E, Moore SB. Blood transfusion and postoperative septic complications. Transfusion. 1994;34:714-727.
20. Busch ORC, Hop WCJ, Marquet RL, et al. Autologous blood and infections after colorectal surgery. Lancet. 1994;343:668-669. Letter.
21. Jensen LS, Kissmeyer-Nielsen P, Wolff B, Qvist N. Randomized comparison of leukocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgery. Lancet. 1996;348:841-845.
22. Houbiers JG, van de Velde CJ, van de Watering LM, et al. Transfusion of red cells is associated with increased incidence of bacterial infection after colorectal surgery: a prospective study. Transfusion. 1997;37:126-134.
23. van de Watering LMG, Houbiers JGA, Hermans J, et al. Leukocyte depletion reduces postoperative mortality in patients undergoing cardiac surgery. In: Proceedings, 24th Congress of the International Society for Blood Transfusion, Makuhari, Japan, 1996, p 37. Abstract SY3DI-06.
24. Blajchman MA. Allogeneic blood transfusions, immunomodulation and postoperative bacterial infection: do we have the answers yet? Transfusion. 1997; 37:121-125. Editorial.
25. Vamvakas E. Transfusion-associated cancer recurrence and infection: meta-analysis of the randomized controlled clinical trials. Transfusion. 1996;36: 175-186.
26. Vamvakas E. Meta-analysis in transfusion medicine. Transfusion. 1997;37: 329-345.
27. Birkmeyer JD, Goodnough LT, AuBuchon JP, et al. The cost-effectiveness of preoperative autologous blood donation for total hip and total knee replacement. Transfusion. 1993;33:544-551.
28. Etchason J, Petz L. Keeler E, et al. The cost-effectiveness of preoperative autologous blood donations. N Engl J Med. 1995;332:719-724.
29. Healy JC, Frankforter SA, Graves BK, et al. Preoperative autologous blood donation in total-hip arthroplasty: a cost-effectiveness analysis. Arch Pathol Lab Med. 1994;118:465-470.
30. Gold MR, Siegel JE, Russell LB, Weinstein MC, eds. Cost-effectiveness in Health and Medicine. New York, NY: Oxford University Press, 1996.
31. AuBuchon JP. Lessons learned from decision analysis. Transfusion. 1996; 36:755-760.
32. Evans RW. A critical perspective on the tools to support clinical decision making. Transfusion. 1996;36:671-673. Editorial.
33. Tartter PI. Blood transfusion and infectious complications following colorectal cancer surgery. Br J Surg. 1988;75:789-792.
34. Wobbes T, Bemelmans BL, Kuypers JH, Beerthuizen GI, Theeuwes AG. Risk of postoperative septic complications after abdominal surgical treatment in relation to perioperative blood transfusion. Surg Gynecol Obstet. 1990; 71:59-62.
35. Jensen LS, Andersen A, Fristrup SC, et al. Comparison of one dose versus three doses of prophylatic antibiotics and the influence of blood transfusion on infectious complications in acute and elective colorectal surgery. Br J Surg. 1990; 77:513-516.
36. Jahnson S, Andersson M. Adverse effects of perioperative blood transfusion in patients with colorectal cancer. Eur J Surg. 1992;158:419-425.
37. Braga JM, Vignali A, Radaelli G, Gianotti L, Dicarlo V. Association between perioperative blood transfusion and postoperative infection in patients having elective operations for gastrointestinal cancer. Eur J Surg. 1992;158:531-536.
38. Vamvakas EC, Carven JH, Hibberd PL. Blood transfusion and infection after colorectal cancer surgery. Transfusion. 1996;36:1000-1008.
39. Miettinen O. Confounding and effect-modification. Am J Epidemiol. 1974; 100:350-353.
40. Hennekens CH, Buring JE. Statistical association and cause-effect relationships. In: Epidemiology in Medicine. Boston, Mass: Little, Brown; 1978; 30-53.
41. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40:373-383.
42. Dirks MR, Craven DE, Celli BR, et al. Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers: the role of gastric colonization. N Engl J Med. 1987;317:1376-1382.
43. Centers for Disease Control and Prevention. National Nosocomial Infections Surveillance System Information Packet. Atlanta, Ga: US Department of Health and Human Services; 1994.
44. Ashby JL Jr. The accuracy of cost measures derived from Medicare cost report data. Hosp Cost Management Account. 1992;3:1-8
45. Finkler SA. The distinction between costs and charges. Ann Intern Med. 1982;96:102-109.
46. Schlesselman JJ. Multivariate analysis. In: Case-Control Studies: Design, Conduct, Analysis. New York, NY: Oxford University Press; 1982:227-290.
47. Friedman LM, Furberg CD, DeMets DL. Fundamentals of Clinical Trials. St. Louis, MO: Mosby-Year Book; 1995.
48. Tran DD, Van Onselen EB, Wensink AJ, Cuesta MA. Factors related to multiple organ system failure and mortality in a surgical intensive care unit. Nephrol Dial Transplant. 1994;9(suppl 4):172-178.
49. Chmell MJ, Schwartz HS. Analysis of variables affecting wound healing after musculoskeletal sarcoma resections. J Surg Oncol. 1996;61:185-189.
50. Habib RH, Zacharias A, Engoren M. Determinants of prolonged mechanical ventilation after coronary artery bypass grafting. Ann Thorac Surg. 1996;62: 1164-1171.
51. Colditz GA, Miller JN, Mosteller F. How study design affects outcomes in comparisons of therapy: I. Medical. Stat Med. 1989;8:441-454.
52. Miller JN, Colditz GA, Mosteller F. How study design affects outcomes in comparisons of therapy: II. Surgical. Stat Med. 1989;8:455-466.